These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23291847)

  • 1. A neonate with reduced cytomegalovirus DNA copy number and marked improvement of hearing in the treatment of congenital cytomegalovirus infection.
    Hayakawa J; Kawakami Y; Takeda S; Ozawa H; Fukazawa R; Takase M; Fukunaga Y
    J Nippon Med Sch; 2012; 79(6):471-7. PubMed ID: 23291847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
    Amir J; Wolf DG; Levy I
    Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
    Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
    J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes.
    Kim Y; Kim YM; Kim DR; Kim HG; Sung JH; Choi SJ; Oh SY; Kim YJ; Chang YS; Kim D; Kim JS; Moon IJ; Roh CR
    J Korean Med Sci; 2023 Aug; 38(32):e249. PubMed ID: 37582499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-year follow-up of congenital cytomegalovirus infection complicated with severe neurological findings in infancy: a case report.
    Suganuma E; Oka A; Sakata H; Adachi N; Asanuma S; Oguma E; Yamaguchi A; Furuichi M; Uejima Y; Sato S; Takano T; Kawano Y; Tanaka R; Arai T; Oh-Ishi T
    BMC Pediatr; 2018 Nov; 18(1):369. PubMed ID: 30470211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
    Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P;
    J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic congenital Cytomegalovirus deafness: the impact of a six-week course of antiviral treatment on hearing improvement.
    Mazzaferri F; Cordioli M; Conti M; Storato S; Be G; Biban P; Concia E; Merighi M
    Infez Med; 2017 Dec; 25(4):347-350. PubMed ID: 29286014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children with congenital cytomegalovirus infection with ganciclovir.
    Michaels MG; Greenberg DP; Sabo DL; Wald ER
    Pediatr Infect Dis J; 2003 Jun; 22(6):504-9. PubMed ID: 12799506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Cytomegalovirus.
    Mestas E
    Adv Neonatal Care; 2016 Feb; 16(1):60-5. PubMed ID: 26752783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital cytomegalovirus: what the otolaryngologist should know.
    Duval M; Park AH
    Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):495-500. PubMed ID: 25222916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs].
    Bührer C; Blankenstein O; Rossi R;
    Z Geburtshilfe Neonatol; 2020 Apr; 224(2):71-78. PubMed ID: 31426118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir.
    Meine Jansen CF; Toet MC; Rademaker CM; Ververs TF; Gerards LJ; van Loon AM
    J Perinat Med; 2005; 33(4):364-6. PubMed ID: 16211780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.
    Choi KY; Sharon B; Balfour HH; Belani K; Pozos TC; Schleiss MR
    J Clin Virol; 2013 Aug; 57(4):356-60. PubMed ID: 23688863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
    Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
    Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
    [No Abstract]   [Full Text] [Related]  

  • 17. Valganciclovir for symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Jester PM; Sánchez PJ; Ahmed A; Arav-Boger R; Michaels MG; Ashouri N; Englund JA; Estrada B; Jacobs RF; Romero JR; Sood SK; Whitworth MS; Abzug MJ; Caserta MT; Fowler S; Lujan-Zilbermann J; Storch GA; DeBiasi RL; Han JY; Palmer A; Weiner LB; Bocchini JA; Dennehy PH; Finn A; Griffiths PD; Luck S; Gutierrez K; Halasa N; Homans J; Shane AL; Sharland M; Simonsen K; Vanchiere JA; Woods CR; Sabo DL; Aban I; Kuo H; James SH; Prichard MN; Griffin J; Giles D; Acosta EP; Whitley RJ;
    N Engl J Med; 2015 Mar; 372(10):933-43. PubMed ID: 25738669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected hearing improvement after treatment with valganciclovir in a child with congenital cytomegalovirus infection.
    Palma S; Mazzoni L; Roversi MF; Botti C; Monzani D; Berardi A; Genovese E
    Folia Med (Plovdiv); 2021 Apr; 63(2):297-301. PubMed ID: 33932024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.
    Nassetta L; Kimberlin D; Whitley R
    J Antimicrob Chemother; 2009 May; 63(5):862-7. PubMed ID: 19287011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
    del Rosal T; Baquero-Artigao F; Blázquez D; Noguera-Julian A; Moreno-Pérez D; Reyes A; Vilas J
    J Clin Virol; 2012 Sep; 55(1):72-4. PubMed ID: 22750017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.